1. Home
  2. TUSK vs ELDN Comparison

TUSK vs ELDN Comparison

Compare TUSK & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TUSK
  • ELDN
  • Stock Information
  • Founded
  • TUSK 2014
  • ELDN 2004
  • Country
  • TUSK United States
  • ELDN United States
  • Employees
  • TUSK N/A
  • ELDN N/A
  • Industry
  • TUSK Oilfield Services/Equipment
  • ELDN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TUSK Energy
  • ELDN Health Care
  • Exchange
  • TUSK Nasdaq
  • ELDN Nasdaq
  • Market Cap
  • TUSK 211.8M
  • ELDN 239.6M
  • IPO Year
  • TUSK 2016
  • ELDN N/A
  • Fundamental
  • Price
  • TUSK $2.79
  • ELDN $4.34
  • Analyst Decision
  • TUSK
  • ELDN Strong Buy
  • Analyst Count
  • TUSK 0
  • ELDN 1
  • Target Price
  • TUSK N/A
  • ELDN $16.00
  • AVG Volume (30 Days)
  • TUSK 103.3K
  • ELDN 553.2K
  • Earning Date
  • TUSK 11-01-2024
  • ELDN 11-12-2024
  • Dividend Yield
  • TUSK N/A
  • ELDN N/A
  • EPS Growth
  • TUSK N/A
  • ELDN N/A
  • EPS
  • TUSK N/A
  • ELDN N/A
  • Revenue
  • TUSK $187,514,000.00
  • ELDN N/A
  • Revenue This Year
  • TUSK N/A
  • ELDN N/A
  • Revenue Next Year
  • TUSK $2.48
  • ELDN N/A
  • P/E Ratio
  • TUSK N/A
  • ELDN N/A
  • Revenue Growth
  • TUSK N/A
  • ELDN N/A
  • 52 Week Low
  • TUSK $2.50
  • ELDN $1.43
  • 52 Week High
  • TUSK $4.94
  • ELDN $5.54
  • Technical
  • Relative Strength Index (RSI)
  • TUSK 26.13
  • ELDN 42.46
  • Support Level
  • TUSK $2.89
  • ELDN $4.32
  • Resistance Level
  • TUSK $3.05
  • ELDN $4.76
  • Average True Range (ATR)
  • TUSK 0.14
  • ELDN 0.39
  • MACD
  • TUSK -0.02
  • ELDN -0.09
  • Stochastic Oscillator
  • TUSK 0.00
  • ELDN 2.65

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated, growth oriented energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. Its suite of services includes well-completion services, infrastructure services, natural sand proppant services, drilling services, and other services. The majority of revenues are earned from the well-completion services and geographically from the United States followed by Canada and other countries.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: